Price $17.98 |
Market Cap
21.7B
|
Sector Health Care |
Div. Growth
-92.30%
|
|
P/E
-
|
P/B
1.44
|
P/S
1.02
|
Dividend %
-
|
|
P/CF
16.8
|
P/FCF
8.2
|
Op. Cash Flow
3.26M
|
FCF
2.4
|
|
Op. Margin
-59.00%
|
Net Margin
-56.00%
|
ROE
-78.00%
|
ROI
-36.00%
|
|
ROA
-16.30%
|
EPS Growth
-85.60%
|
Current Ratio
0.9
|
Debt/Equity
210.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.7M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.68 | - | - | 48.7M | Strong Buy |
| IRIDEX Corporation (IRIX) | $4.50 | - | - | 64.3M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.14 | - | - | 73.9M | Strong Buy |
| Horizon Pharma PLC (HZNP) | $23.17 | - | - | 3.6B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
